These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37551875)

  • 21. Risk of coronary artery lesions in young infants with Kawasaki disease: need for a new diagnostic method.
    Satoh K; Wakejima Y; Gau M; Kiguchi T; Matsuda N; Takasawa R; Takasawa K; Nishioka M; Shimohira M
    Int J Rheum Dis; 2018 Mar; 21(3):746-754. PubMed ID: 29105337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B-type natriuretic peptide and N-terminal pro-BNP in the acute phase of Kawasaki disease.
    Iwashima S; Ishikawa T
    World J Pediatr; 2013 Aug; 9(3):239-44. PubMed ID: 23335186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Pentraxin 3 Levels Correlate With IVIG Responsiveness and Coronary Artery Aneurysm Formation in Kawasaki Disease.
    Kitoh T; Ohara T; Muto T; Okumura A; Baba R; Koizumi Y; Yamagishi Y; Mikamo H; Daigo K; Hamakubo T
    Front Immunol; 2021; 12():624802. PubMed ID: 33912155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis: Diagnostic Value of N-Terminal Pro-brain Natriuretic Peptide for Kawasaki Disease.
    Yu J; Li HH; Dong L
    Clin Lab; 2016 Oct; 62(10):1903-1910. PubMed ID: 28164518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression levels of plasma miRNA-21 and NT-proBNP in children with Kawasaki disease and their clinical significance.
    Zhang R; Wu L; Zhang HJ; Gao XJ; Pan XT; Wang XR; Ye H; Liu GH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12757-12762. PubMed ID: 33378024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood N-terminal Pro-brain Natriuretic Peptide and Interleukin-17 for Distinguishing Incomplete Kawasaki Disease from Infectious Diseases.
    Wu L; Chen Y; Zhong S; Li Y; Dai X; Di Y
    Indian Pediatr; 2015 Jun; 52(6):477-80. PubMed ID: 26121721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease.
    Rodriguez-Gonzalez M; Perez-Reviriego AA; Castellano-Martinez A; Cascales-Poyatos HM
    Biomark Med; 2019 Mar; 13(4):307-323. PubMed ID: 30900472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-terminal pro-brain natriuretic peptide and cardiac troponin I for the prognostic utility in elderly patients with severe sepsis or septic shock in intensive care unit: A retrospective study.
    Cheng H; Fan WZ; Wang SC; Liu ZH; Zang HL; Wang LZ; Liu HJ; Shen XH; Liang SQ
    J Crit Care; 2015 Jun; 30(3):654.e9-14. PubMed ID: 25575850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. N-terminal pro-brain natriuretic peptide (NT proBNP) as a predictive indicator of initial intravenous immunoglobulin treatment failure in children with Kawasaki disease: a retrospective study.
    Kim SY; Han MY; Cha SH; Jeon YB
    Pediatr Cardiol; 2013; 34(8):1837-43. PubMed ID: 23744100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K; Kimata T; Mine K; Uchiyama T; Tsuji S; Kaneko K
    J Pediatr; 2013 Jun; 162(6):1205-9. PubMed ID: 23290510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of N-terminal pro-brain natriuretic peptide in evaluating early septic cardiac dysfunction in neonates].
    Yang C; Liu F; Han M; Li B; Shen Q; Xu P; Yang Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):711-715. PubMed ID: 32684218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of Serum NT-proBNP and Endogenous H₂S for Predicting Coronary Artery Lesions in Pediatric Kawasaki Disease.
    Song HB; Zhang YD; Dong QW; Han LP; Qi RF; Bi BB; Ma L; Ma L; Zhang H
    J Coll Physicians Surg Pak; 2020 Jan; 30(1):37-40. PubMed ID: 31931930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of the risk of coronary arterial lesions in Kawasaki disease by brain natriuretic peptide.
    Kaneko K; Yoshimura K; Ohashi A; Kimata T; Shimo T; Tsuji S
    Pediatr Cardiol; 2011 Dec; 32(8):1106-9. PubMed ID: 21487793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Procalcitonin and N-Terminal Pro-B-Type Natriuretic Peptide for Prognosis in Septic Acute Kidney Injury Patients Receiving Renal Replacement Therapy.
    Sheng X; Yang J; Yu G; Fei Y; Bao H; Yin J; Huang W; Tian Z; Wang N; Ronco C
    Blood Purif; 2019; 48(3):262-271. PubMed ID: 31311006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of NT-proBNP levels in the acute phase of sepsis on lower long-term physical function and muscle strength in sepsis survivors.
    Custodero C; Wu Q; Ghita GL; Anton SD; Brakenridge SC; Brumback BA; Efron PA; Gardner AK; Leeuwenburgh C; Moldawer LL; Petersen JW; Moore FA; Mankowski RT
    Crit Care; 2019 Jun; 23(1):230. PubMed ID: 31234943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-reactive protein and N-terminal pro-brain natriuretic peptide discrepancy: a differentiation of adenoviral pharyngoconjunctival fever from Kawasaki disease.
    Choi JE; Kang HW; Hong YM; Sohn S
    Korean J Pediatr; 2018 Jan; 61(1):12-16. PubMed ID: 29441107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of COVID-19-Associated Multisystem Inflammatory Syndrome From Kawasaki Disease With the Use of Cardiac Biomarkers.
    Fridman MD; Tsoukas P; Jeewa A; Yeung RSM; Gamulka BD; McCrindle BW
    Can J Cardiol; 2023 Jun; 39(6):815-823. PubMed ID: 36462758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum N-terminal pro-brain natriuretic peptide level is a significant prognostic factor in patients with severe sepsis among Southwest Chinese population.
    Zhang XH; Dong Y; Chen YD; Zhou P; Wang JD; Wen FQ
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):517-21. PubMed ID: 23467952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmortem urine concentration of N-terminal pro-brain natriuretic peptide in relation to the cause of death.
    Takasu S; Matsumoto S; Kanto Y; Kodama S; Iwadate K
    Forensic Sci Int; 2020 Jan; 306():110079. PubMed ID: 31812084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.